Success Metrics

Clinical Success Rate
84.6%

Based on 22 completed trials

Completion Rate
85%(22/26)
Active Trials
2(6%)
Results Posted
64%(14 trials)
Terminated
4(13%)

Phase Distribution

Ph phase_1
12
38%
Ph not_applicable
1
3%
Ph phase_3
8
25%
Ph phase_2
8
25%
Ph phase_4
3
9%

Phase Distribution

12

Early Stage

8

Mid Stage

11

Late Stage

Phase Distribution32 total trials
Phase 1Safety & dosage
12(37.5%)
Phase 2Efficacy & side effects
8(25.0%)
Phase 3Large-scale testing
8(25.0%)
Phase 4Post-market surveillance
3(9.4%)
N/ANon-phased studies
1(3.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.5%

22 of 27 finished

Non-Completion Rate

18.5%

5 ended early

Currently Active

2

trials recruiting

Total Trials

32

all time

Status Distribution
Active(3)
Completed(22)
Terminated(5)
Other(2)

Detailed Status

Completed22
Terminated4
unknown2
Recruiting2
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
2
Success Rate
84.6%
Most Advanced
Phase 4

Trials by Phase

Phase 112 (37.5%)
Phase 28 (25.0%)
Phase 38 (25.0%)
Phase 43 (9.4%)
N/A1 (3.1%)

Trials by Status

unknown26%
completed2269%
recruiting26%
terminated413%
not_yet_recruiting13%
withdrawn13%

Recent Activity

2 active trials
Showing 5 of 32
completedphase_1

Staccato Loxapine Thorough QT/QTc Study

NCT00874237
completedphase_1

Staccato Prochlorperazine Single Dose PK Study

NCT00610727
completedphase_3

Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department

NCT03257319
completedphase_3

Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia

NCT03149640
recruitingphase_2

Inhaled Isopropyl Alcohol for Treatment of Nausea

NCT05418244
View all 32 trials

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT00874237Phase 1

Staccato Loxapine Thorough QT/QTc Study

Completed
NCT00610727Phase 1

Staccato Prochlorperazine Single Dose PK Study

Completed
NCT03257319Phase 3

Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department

Completed
NCT03149640Phase 3

Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia

Completed
NCT05418244Phase 2

Inhaled Isopropyl Alcohol for Treatment of Nausea

Recruiting
NCT04193878Phase 3

ARrest RESpiraTory Failure From PNEUMONIA

Terminated
NCT03656081Phase 3

Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole

Recruiting
NCT06819462Not Applicable

Inhaled Polymyxin E to Prevent VAP

Not Yet Recruiting
NCT00302211Phase 3

The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension

Terminated
NCT02595060Phase 2

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Inhalation to Improve Host Defense and Pulmonary Barrier Restoration

Completed
NCT03669614Phase 1

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

Unknown
NCT04148963Phase 3

A Study of Staccato Loxapine (ADASUVE®) for Inhalation

Unknown
NCT00543062Phase 1

Staccato Prochlorperazine Thorough QT/QTc

Completed
NCT00789360Phase 1

Staccato Loxapine Pulmonary Safety in Healthy Volunteers

Completed
NCT03309358Phase 1

A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

Terminated
NCT00682929Phase 1

Cannabis for Spasticity in Multiple Sclerosis

Terminated
NCT00422812Phase 2

Staccato Prochlorperazine in Migraine (Out Patient)

Completed
NCT00369577Phase 2

Staccato Loxapine in Agitation (Proof of Concept)

Completed
NCT01877642Phase 4

ADASUVE-Lorazepam Drug-Drug Interaction

Completed
NCT01854710Phase 4

ADASUVE 2-dose Thorough QT/QTc Study

Completed

Drug Details

Intervention Type
DRUG
Total Trials
32